Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Crystallin beta B2 pseudogene 1 (CRYBB2P1) is classified as a pseudogene in the human genome. It is a non-coding DNA segment related to the functional crystallin beta B2 gene (CRYBB2), which encodes a structural protein essential for maintaining lens transparency. The pseudogene itself does not produce a functional protein, and there is no evidence it serves as a direct therapeutic target. Some studies note that it may be expressed at higher levels in certain tumors, such as breast cancer, but it is not currently implicated in specific disease mechanisms or drug interactions. This entity is not an actionable or druggable therapeutic target, and its main relevance is as an annotated pseudogene homologous to a structural lens protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crystallin beta B2 pseudogene 1 (CRYBB2P1).